Sunosi (solriamfetol) significantly improved cognitive function as compared to placebo in cognitively impaired patients with excessive daytime sleepiness associated with obstructive sleep apnea.
Axsome Therapeutics (AXSM) Reports Sunosi Met Primary Endpoint in SHARP Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.